All Section

All SMSNA News

FDA Label Change on Approved Testosterone Products: Blood Clots Unrelated to Polycythemia

SMSNA Patients
The U.S. Food and Drug Administration (FDA) has asked all manufacturers of FDA-approved testosterone products to include a warning about blood clots in the veins that are notrelated to polycythemia. Polycythemia refers to increased levels of red blood cells and is a possible side effect of testosterone treatment.  FDA-approved testosterone products already carry a warning about...
FDA Label Change on Approved Testosterone Products: Blood Clots Unrelated to Polycythemia

Testosterone and Immunity

SMSNA Patients
Men with higher levels of testosterone might have weakened immune systems, at least in terms of...

SMSNA

SMSNA Patients

Attention: Restrictions on use of SMSNA content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.

You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.

Subscribe for our Newsletter!

Subscribe Now
Image

SMSNA

Fellowship

For Patients